Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery

Acta Anaesthesiologica Scandinavica

Volumn 50, Issue 8, 2006, Pages 962-969

  Koskenkari, J K ^a,c   Kaukoranta, K ^a   Rimpilainen J ^a   Vainionpaa V ^a   Ohtonen, P P ^a   Surcel, H M ^b   Juvonen, T ^a   Ala Kokko, T I ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c Box 21 ^*  (Finland)

Author keywords

Cardiopulmonary bypass; Inflammatory response; Post operative care

Indexed keywords

ALFENTANIL; APROTININ; C REACTIVE PROTEIN; CREATININE; FATTY ACID; FENTANYL; GLUCOSE; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; ISOFLURANE; NEUTRAL INSULIN; PANCURONIUM; POTASSIUM CHLORIDE; PROPOFOL; SODIUM CHLORIDE; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HEART INDEX; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INSULIN TREATMENT; INTENSIVE CARE UNIT; LUNG VASCULAR RESISTANCE; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SYSTEMIC VASCULAR RESISTANCE; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOPLEGIC SOLUTIONS; EMERGENCY TREATMENT; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL REVASCULARIZATION; POTASSIUM; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33747739453     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01100.x     Document Type: Article

References (22)

1. Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart 2002; 87: 201-4.
2. Apstein CS. Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury. Am Heart J 2000; 139: S107-14.
3. Kaiser GC, Schaff HV, Killip T. Myocardial revascularization for unstable angina pectoris. Circulation 1989; 79: I60-7.
4. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS et al. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 2000; 101: 2090-6.
5. Svedjeholm R, Huljebrant I, Håkanson E, Vanhanen I. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations. Ann Thorac Surg 1995; 59: S23-30.
6. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berhe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88: 1082-8.
7. Brix-Christensen V, Andersen SK, Andersen R, Mengel R, Dyhr T, Andersen NT et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology 2004; 100: 861-70.
8. Koskenkari JK, Kaukoranta PK, Kiviluoma KT, Raatikainen MJ, Ohtonen PP, Ala-Kokko TI. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. Ann Thorac Surg 2005; 80: 511-7.
9. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RR, Rebuzzi AG, Pepys MB et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
10. Biancari F, Lahtinen J, Lepojarvi S, Rainio P, Salmela E, Pokela R et al. Preoperative C-reactive protein and outcome after coronary artery bypass surgery. Ann Thorac Surg 2003; 76: 2007-12.
11. Visser L, Zuurbier CJ, Hoek FJ, Opmeer BC, de Jonge E, de Mol BA et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 2005; 95: 448-57.
12. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopabhyay A et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004; 109: 849-54.
13. Tassani P, Augustin N, Barankay A, Braun SL, Zaccaria F, Richter JA. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2000; 14: 682-6.
14. Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 2004; 78: 54-9.
15. Franke A, Lante W, Fackeldey V, Becker HP, Thode C, Kuhlmann WD et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 2005; 28: 569-75.
16. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067-72.
17. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003; 26: 3129-35.
18. Krogh-Madsen R, Moller K, Dela F, Kronborg G, Jauffred S, Klarlund Pedersen B. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2004; 286: E766-72.
19. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23: 599-622.
20. Bothe W, Olschewski M, Beyersdorf F, Doenst T. Glucoseinsulin-potassium in cardiac surgery: a meta-analysis. Ann Thorac Surg 2004; 78: 1650-7.
21. Sundell J, Knuuti J. Insulin and myocardial blood flow. Cardiovasc Res 2003; 57: 312-9.
22. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.